Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients
- PMID: 19129279
- DOI: 10.1183/09031936.00112408
Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients
Abstract
Several cellular and molecular alterations have been described in skeletal and respiratory muscles of patients with chronic obstructive pulmonary disease (COPD), but information on potential abnormalities of mitochondrial function is scarce. The aim of the present study was to investigate mitochondrial function in the vastus lateralis (VL) and external intercostalis (EI) of COPD patients. Biopsies from VL and EI were obtained during surgery for lung cancer in 13 patients with mild to moderate COPD (age 68+/-6 yrs, forced expiratory volume in one second (FEV(1)) 66+/-15% predicted) and 19 control subjects (age 67+/-9 yrs, FEV(1) 95+/-18% pred). State 3 and 4 mitochondrial oxygen consumption (V'(O(2),m)), ATP synthesis, citrate synthase, cytochrome oxidase (COX) and complex I-III activities, as well as reactive oxygen species (ROS) production, were determined. In COPD patients, in both muscles, COX activity (VL: COPD 3.0+/-0.8 versus control 2.0+/-0.8; EI: 3.7+/-1.6 versus 2.4+/-0.9 micromol min(-1) mg(-1)) and ROS production (VL: 1,643+/-290 versus 1,285+/-468; EI: 1,033+/-210 versus 848+/-288 arbitrary units) were increased, whereas state 3 V'(O(2),m) was reduced (VL: 2.9+/-0.3 versus 3.6+/-0.4; EI: 3.6+/-0.3 versus 4.1+/-0.4 mmol min(-1) kg(-1)). Skeletal muscle mitochondria of patients with chronic obstructive pulmonary disease show electron transport chain blockade and excessive production of reactive oxygen species. The concurrent involvement of both vastus lateralis and external intercostalis suggests a systemic (rather than a local) mechanism(s) already occurring in relatively early stages (Global Initiative for Chronic Obstructive Lung Disease stage II) of the disease.
Similar articles
-
Skeletal muscle mitochondrial dysfunction during chronic obstructive pulmonary disease: central actor and therapeutic target.Exp Physiol. 2013 Jun;98(6):1063-78. doi: 10.1113/expphysiol.2012.069468. Epub 2013 Feb 1. Exp Physiol. 2013. PMID: 23377494 Review.
-
Metabolic derangements in COPD muscle dysfunction.J Appl Physiol (1985). 2013 May;114(9):1282-90. doi: 10.1152/japplphysiol.00815.2012. Epub 2013 Jan 3. J Appl Physiol (1985). 2013. PMID: 23288549 Review.
-
Site of mitochondrial reactive oxygen species production in skeletal muscle of chronic obstructive pulmonary disease and its relationship with exercise oxidative stress.Am J Respir Cell Mol Biol. 2012 Sep;47(3):358-62. doi: 10.1165/rcmb.2011-0382OC. Epub 2012 Apr 5. Am J Respir Cell Mol Biol. 2012. PMID: 22493009
-
Altered mitochondrial regulation in quadriceps muscles of patients with COPD.Clin Physiol Funct Imaging. 2011 Mar;31(2):124-31. doi: 10.1111/j.1475-097X.2010.00988.x. Epub 2010 Nov 22. Clin Physiol Funct Imaging. 2011. PMID: 21091605
-
Abnormal transition pore kinetics and cytochrome C release in muscle mitochondria of patients with chronic obstructive pulmonary disease.Am J Respir Cell Mol Biol. 2009 Jun;40(6):746-50. doi: 10.1165/rcmb.2008-0289OC. Epub 2008 Nov 14. Am J Respir Cell Mol Biol. 2009. PMID: 19011161
Cited by
-
Effects of Ninjin'yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial.Int J Chron Obstruct Pulmon Dis. 2024 May 7;19:995-1010. doi: 10.2147/COPD.S441767. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38737191 Free PMC article. Clinical Trial.
-
Research progress of mitochondria in chronic obstructive pulmonary disease: a bibliometric analysis based on the Web of Science Core Collection.J Thorac Dis. 2024 Jan 30;16(1):215-230. doi: 10.21037/jtd-23-777. Epub 2024 Jan 9. J Thorac Dis. 2024. PMID: 38410585 Free PMC article.
-
Chronic aryl hydrocarbon receptor activity impairs muscle mitochondrial function with tobacco smoking.J Cachexia Sarcopenia Muscle. 2024 Apr;15(2):646-659. doi: 10.1002/jcsm.13439. Epub 2024 Feb 9. J Cachexia Sarcopenia Muscle. 2024. PMID: 38333944 Free PMC article.
-
Main Pathogenic Mechanisms and Recent Advances in COPD Peripheral Skeletal Muscle Wasting.Int J Mol Sci. 2023 Mar 29;24(7):6454. doi: 10.3390/ijms24076454. Int J Mol Sci. 2023. PMID: 37047427 Free PMC article. Review.
-
Glycyl-l-histidyl-l-lysine-Cu2+ rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway.J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1365-1380. doi: 10.1002/jcsm.13213. Epub 2023 Mar 10. J Cachexia Sarcopenia Muscle. 2023. PMID: 36905132 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous